Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving time to diagnosis and discharge in clinical decision units: the impact of progression of care huddles.

Journal of health organization and management·2026
Same author

Asymptomatic Candiduria due to <i>Candida inconspicua</i> in a Patient With Hematologic Malignancy.

Case reports in infectious diseases·2026
Same author

Chilean Association of Digestive Endoscopy (ACHED) guidelines for the detection of early gastric cancer and surveillance of gastric premalignant conditions in high-risk populations.

Gastroenterologia y hepatologia·2025
Same author

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile.

PloS one·2025
Same author

A key role of polyamine metabolism in adipose tissue homeostasis that regulates obesity.

Metabolism: clinical and experimental·2025
Same author

Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Nov 15, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

14.0K

[First isolation de Candida auris in Chile].

María Victoria Moreno1, María Elvira Simian2, Javier Villarroel3

  • 1Laboratorio Clínico, Hospital del Salvador, Santiago, Chile.

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|March 4, 2021
PubMed
Summary
This summary is machine-generated.

A multi-drug-resistant fungus, Candida auris, was identified in Santiago from a patient returning from India. This emerging pathogen shows resistance to fluconazole, posing a significant healthcare challenge.

More Related Videos

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.5K
Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.0K

Related Experiment Videos

Last Updated: Nov 15, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

14.0K
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.5K
Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
04:37

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections

Published on: February 2, 2024

1.0K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Candida auris is an emerging multidrug-resistant fungus causing global hospital-associated infections.
  • Simultaneous outbreaks and laboratory misidentification complicate C. auris infection management.
  • Rarely observed in non-albicans Candida species, C. auris presents challenges in eradication and treatment.

Purpose of the Study:

  • To report the first isolation of Candida auris in Santiago, Chile.
  • To characterize the antimicrobial resistance profile of the isolated C. auris strain.
  • To highlight the clinical and epidemiological significance of C. auris emergence.

Main Methods:

  • Isolation of C. auris from a patient's tissue culture.
  • Identification using VITEK® 2 Compact system.
  • Confirmation through MALDI-TOF MS and DNA sequence analysis.
  • Antimicrobial susceptibility testing.

Main Results:

  • The first C. auris strain in Santiago was isolated from a patient with diabetic foot complications, who had traveled from India.
  • The isolate was identified using VITEK® 2 Compact, MALDI-TOF MS, and DNA sequencing.
  • The C. auris strain exhibited resistance to fluconazole, with susceptibility to amphotericin B and caspofungin.

Conclusions:

  • The emergence of C. auris in new geographical locations is a growing concern.
  • Accurate and rapid identification methods are crucial for managing C. auris infections.
  • The unclear transmission modes within healthcare settings necessitate further investigation and enhanced infection control measures.